MY201505A - Complexes for treating sensitivity - Google Patents

Complexes for treating sensitivity

Info

Publication number
MY201505A
MY201505A MYPI2019005229A MYPI2019005229A MY201505A MY 201505 A MY201505 A MY 201505A MY PI2019005229 A MYPI2019005229 A MY PI2019005229A MY PI2019005229 A MYPI2019005229 A MY PI2019005229A MY 201505 A MY201505 A MY 201505A
Authority
MY
Malaysia
Prior art keywords
complexes
amorphous calcium
stannous
phosphate
per mole
Prior art date
Application number
MYPI2019005229A
Other languages
English (en)
Inventor
Eric Charles Reynolds
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017900892A external-priority patent/AU2017900892A0/en
Application filed by Univ Melbourne filed Critical Univ Melbourne
Publication of MY201505A publication Critical patent/MY201505A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • A61K8/21Fluorides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/16Fluorine compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24Phosphorous; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58Metal complex; Coordination compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MYPI2019005229A 2017-03-14 2018-03-14 Complexes for treating sensitivity MY201505A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2017900892A AU2017900892A0 (en) 2017-03-14 Complexes for treating sensitivity
PCT/AU2018/050230 WO2018165707A1 (en) 2017-03-14 2018-03-14 Complexes for treating sensitivity

Publications (1)

Publication Number Publication Date
MY201505A true MY201505A (en) 2024-02-27

Family

ID=63521649

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019005229A MY201505A (en) 2017-03-14 2018-03-14 Complexes for treating sensitivity

Country Status (15)

Country Link
US (2) US12303548B2 (enExample)
EP (1) EP3595630A4 (enExample)
JP (1) JP7138352B2 (enExample)
KR (1) KR102555722B1 (enExample)
CN (1) CN110475539A (enExample)
AU (1) AU2018233576B2 (enExample)
BR (1) BR112019018871A2 (enExample)
CA (1) CA3055086A1 (enExample)
EA (1) EA201991935A1 (enExample)
MX (1) MX2019010833A (enExample)
MY (1) MY201505A (enExample)
NZ (1) NZ757004A (enExample)
PH (1) PH12019550156A1 (enExample)
SG (1) SG11201907950VA (enExample)
WO (1) WO2018165707A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2755277T3 (es) 2006-02-09 2020-04-22 Univ Melbourne Composición de fluoruro y métodos para mineralización dental
KR102221531B1 (ko) 2013-07-23 2021-03-02 더 유니버시티 오브 멜버른 치아 광화를 위한 조성물 및 방법
US10912722B2 (en) 2013-12-24 2021-02-09 The University Of Melbourne Stabilized stannous compositions
SG11201907950VA (en) 2017-03-14 2019-09-27 Univ Melbourne Complexes for treating sensitivity
WO2018165708A1 (en) 2017-03-14 2018-09-20 The University Of Melbourne Treatment for gingivitis

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864471A (en) 1968-12-20 1975-02-04 Colgate Palmolive Co Stable dentifrices containing a monofluorophosphate, an insoluble metaphosphate, and calcium carbonate
US3966901A (en) 1970-12-29 1976-06-29 Colgate-Palmolive Company Dentifrice preparation
US4080440A (en) 1974-12-13 1978-03-21 The Procter & Gamble Company Method for remineralizing tooth enamel
US4157386A (en) 1978-05-18 1979-06-05 Rochelle Paul J Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing
US4588763A (en) 1978-06-01 1986-05-13 Braennstroem Martin Ethyl acetate as solvent in cavity liners
NZ199891A (en) 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4357318A (en) 1981-07-31 1982-11-02 Richardson-Vicks Inc. Dentifrices with improved soluble fluoride availability
US4522805A (en) 1983-06-08 1985-06-11 Norman Gordon Tooth and gum dentifrice
US4672032A (en) 1983-11-09 1987-06-09 University Of Southern California Dental enamel production
US5015628A (en) 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
CA1315480C (en) 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
US6056930A (en) 1989-05-24 2000-05-02 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5227154A (en) 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
KR100238551B1 (ko) 1992-06-29 2000-02-01 도우글라스 웨이르 민감성 치아 치료
US5447732A (en) * 1992-11-25 1995-09-05 Ajinomoto Co., Inc. High-absorption mineral-containing composition and foods
CH684773A5 (fr) 1992-12-28 1994-12-30 Nestle Sa Composition alimentaire anti-cariogène.
JP3471431B2 (ja) 1994-07-18 2003-12-02 株式会社ジーシー 歯科用グラスアイオノマーセメント組成物
JP3340265B2 (ja) 1994-11-21 2002-11-05 一枝 山岸 歯の漂白剤
KR0140248B1 (ko) 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
PT748591E (pt) 1995-06-16 2002-04-29 Nestle Sa Caseinas micelares fluoradas
US6036944A (en) 1995-08-08 2000-03-14 Enamelon, Inc. Processes for the remineralization and mineralization of teeth
JP2974604B2 (ja) 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP4040705B2 (ja) 1996-01-24 2008-01-30 株式会社サンギ 口腔組成物
AUPN898296A0 (en) 1996-03-28 1996-04-26 Nulite Systems International Pty Ltd Elastomeric state glass ionomer cement
US5741773A (en) 1996-04-26 1998-04-21 Colgate Palmolive Company Storage stable dentifrice composition containing an antibacterial casein glycomacropeptide adjuvant
JP2975337B2 (ja) 1997-02-20 1999-11-10 雪印乳業株式会社 カルシウム複合体
AUPO566297A0 (en) 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
JPH11228327A (ja) 1998-02-18 1999-08-24 Gc Corp 歯科用ペースト系グラスアイオノマーセメント組成物
JP3742523B2 (ja) 1998-02-27 2006-02-08 雪印乳業株式会社 高分子型カルシウム・ホスホペプチド複合体
US6120754A (en) 1998-03-11 2000-09-19 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Remineralization of teeth
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US6846500B1 (en) 1999-03-25 2005-01-25 Cadbury Adams Usa Llc Oral care chewing gums and method of use
AU2633900A (en) 1999-03-25 2000-10-16 Warner-Lambert Company Oral care chewing gums and confections
FR2791573B1 (fr) 1999-03-30 2003-04-11 Pf Medicament Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
US6149894A (en) 1999-05-14 2000-11-21 Colgate Palmolive Company Method for the manufacture of toothpaste
US6521215B2 (en) 1999-05-28 2003-02-18 Devin Okay Compositions and methods for tooth treatment
US6685920B2 (en) 1999-11-12 2004-02-03 The Procter & Gamble Company Method of protecting teeth against erosion
JP2001144695A (ja) 1999-11-17 2001-05-25 Matsushita Electric Ind Co Ltd 音声処理装置及び音声処理方法
GB9929919D0 (en) 1999-12-17 2000-02-09 Hannah Research Inst The Calcium phosphate nanoclusters and their applications
US7727539B2 (en) 2001-03-14 2010-06-01 Drexel University Polymeric bioresorbable composites containing an amorphous calcium phosphate polymer ceramic for bone repair and replacement
AUPR517701A0 (en) 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
MXPA04006541A (es) 2002-01-03 2004-10-04 Procter & Gamble Composiciones bucales estables que contienen complejos de fosfopeptido de caseina y fluoruro.
CA2469431C (en) 2002-01-03 2009-05-26 The Procter & Gamble Company Stable oral compositions comprising casein phosphopeptide complexes and fluoride
NZ522071A (en) 2002-10-18 2005-07-29 Patrick Joseph Silcock Hydrolysed casein phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation
EP1603525B1 (en) 2002-12-27 2009-04-01 Kao Corporation Oral preparation system
JP3853785B2 (ja) 2002-12-27 2006-12-06 花王株式会社 口腔用組成物
JP4340069B2 (ja) 2003-01-10 2009-10-07 雪印乳業株式会社 カルシウム複合体の製造法
US20050089481A1 (en) 2003-10-23 2005-04-28 Gc Corporation Composition for caries prevention
JP2005145952A (ja) 2003-10-23 2005-06-09 Gc Corp う蝕予防用組成物
US20050118115A1 (en) 2003-10-24 2005-06-02 Fontenot Mark G. Accelerated tooth whitening method, composition and kit
US20060183081A1 (en) 2004-09-27 2006-08-17 Al Bevilacqua Tooth bleaching system and method
NZ555335A (en) 2004-11-25 2010-10-29 Univ Melbourne Phosphopeptide stabilised amorphous calcium phosphate complexes produced under acidic conditions
CA2611077C (en) 2005-06-07 2014-07-15 The University Of Melbourne Dental mineralization
PL1901702T3 (pl) 2005-06-24 2015-07-31 Univ Melbourne Kompleksy jonowe
EP1928265A2 (en) 2005-08-22 2008-06-11 Conagra Foods Packaged Foods Company, Inc. Cryogenic peeling process
JP5684454B2 (ja) 2005-11-25 2015-03-11 “ダブリューディーエス” カンパニー 口腔ケア用の治療及び予防組成物
US20070254260A1 (en) 2005-12-02 2007-11-01 Alden Wayne S Iv Oral care compositions, methods, devices and systems
ES2755277T3 (es) 2006-02-09 2020-04-22 Univ Melbourne Composición de fluoruro y métodos para mineralización dental
WO2008089066A1 (en) 2007-01-12 2008-07-24 Mcneil-Ppc, Inc. Mineralization toothpaste
CN107080702A (zh) * 2008-02-08 2017-08-22 高露洁-棕榄公司 口腔护理产品及其使用和制备方法
RU2543656C2 (ru) 2008-02-08 2015-03-10 Колгейт-Палмолив Компани Продукт для ухода за полостью рта и способы его применения и производства
GB0807224D0 (en) 2008-04-21 2008-05-28 Univ Dundee Remineralisation of calcified tissue
US9849310B2 (en) 2008-06-24 2017-12-26 Dental Alliance Holdings, Llc Dental appliance, oral care product and method of preventing dental disease
US9226895B2 (en) 2008-07-30 2016-01-05 Ultradent Products, Inc. Methods and kits for cleaning and remineralizing teeth
JP2010047494A (ja) 2008-08-20 2010-03-04 Gc Corp 歯牙塗布用組成物
JP5437692B2 (ja) 2009-04-30 2014-03-12 インターコンチネンタル グレート ブランズ エルエルシー チューインガム組成物、チューインガム製品、及びこれらの製造方法
MX2011011486A (es) 2009-05-18 2011-11-18 Colgate Palmolive Co Composiciones orales que contienen compuestos de poliguandino y metodos de preparacion y uso de las mismas.
JP4693191B2 (ja) 2009-08-06 2011-06-01 日本歯科薬品株式会社 口腔用剤
JP2011073983A (ja) 2009-09-29 2011-04-14 Gc Corp 歯牙塗布用組成物
JP2011162470A (ja) * 2010-02-09 2011-08-25 Gc Corp 歯牙用被覆材
MX2012009313A (es) 2010-02-12 2012-11-06 Theocorp Holding Co Llc Metodos y composiciones para mejorar la resistencia mecanica de los dientes.
US9539445B2 (en) 2010-11-22 2017-01-10 Taipei Medical University Type of anion-containing calcium phosphate compound for dental remineralization
EP3424516A1 (en) 2011-01-24 2019-01-09 Basf Se Oral health improving compositions
CN104011574A (zh) 2011-12-27 2014-08-27 住友电气工业株式会社 光缆
JP2013163656A (ja) 2012-02-10 2013-08-22 Gc Corp 歯磨剤
GB201202341D0 (en) 2012-02-10 2012-03-28 Periproducts Ltd Multicomponent oral care compostion
WO2014050144A1 (ja) 2012-09-28 2014-04-03 江崎グリコ株式会社 象牙細管封鎖剤
KR102221531B1 (ko) 2013-07-23 2021-03-02 더 유니버시티 오브 멜버른 치아 광화를 위한 조성물 및 방법
US10912722B2 (en) * 2013-12-24 2021-02-09 The University Of Melbourne Stabilized stannous compositions
CN104001157B (zh) * 2014-05-27 2015-12-02 高益槐 一种防治骨质疏松症的复方制剂及其制备方法
KR20170100580A (ko) * 2014-12-24 2017-09-04 더 유니버시티 오브 멜버른 광화 플루오라이드 조성물
SG11201907950VA (en) 2017-03-14 2019-09-27 Univ Melbourne Complexes for treating sensitivity
WO2018165708A1 (en) 2017-03-14 2018-09-20 The University Of Melbourne Treatment for gingivitis
KR20210139320A (ko) 2019-03-13 2021-11-22 더 유니버시티 오브 멜버른 저광화된 병변의 은폐

Also Published As

Publication number Publication date
EA201991935A1 (ru) 2020-02-14
SG11201907950VA (en) 2019-09-27
EP3595630A4 (en) 2021-01-13
KR102555722B1 (ko) 2023-07-13
US12303548B2 (en) 2025-05-20
PH12019550156A1 (en) 2020-03-16
JP7138352B2 (ja) 2022-09-16
KR20190126134A (ko) 2019-11-08
EP3595630A1 (en) 2020-01-22
BR112019018871A2 (pt) 2020-04-14
CN110475539A (zh) 2019-11-19
NZ757004A (en) 2023-05-26
US20250152666A1 (en) 2025-05-15
JP2020514351A (ja) 2020-05-21
MX2019010833A (es) 2019-10-30
AU2018233576B2 (en) 2021-06-24
CA3055086A1 (en) 2018-09-20
AU2018233576A1 (en) 2019-09-26
WO2018165707A1 (en) 2018-09-20
US20200197486A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
PH12019550156A1 (en) Complexes for treating sensitivity
MX2018014969A (es) Una composicion para el cuidado bucal.
PH12018500642A1 (en) Anti-garp antibody
MY201925A (en) Macrocyclic compounds and uses thereof
ZA201901536B (en) Nicotinamide riboside and pterostilbene compositions and methods for treatment of neurodegenerative disorders
MX359754B (es) Composiciones orales que contienen fuentes de ion de zinc, estaño y fluoruro.
MY193524A (en) Diaryl macrocycles as modulators of protein kinases
MX2020002254A (es) Compuestos espirociclicos y sus metodos de preparacion y uso.
PH12016501218B1 (en) Stabilized stannous compositions
PH12020500372A1 (en) Spirocycle compounds and methods of making and using same
PH12016501732B1 (en) Formulation for soft anticholinergic analogs
MY201080A (en) Nlrp3 modulators
MY195081A (en) Pladienolide Pyridine Compounds and Methods of use
MY187945A (en) Improved mouthwash preparation
PH12019502036A1 (en) Peptides and methods for the treatment of diabetes
PH12019550157A1 (en) Treatment for gingivitis
MX2017013047A (es) Tratamiento de dolor.
SG10201805890QA (en) Compositions and methods for treatment of abnormal cell growth
ZA201802606B (en) Compositions for dental varnishes and methods of making and using same
EP4218789A3 (en) Compositions for colon cleansing and the treatment of gastrointestnal disorders
MX2020012805A (es) Compuestos para el tratamiento del dolor, composiciones que comprenden los mismos, y metodos para utilizar los mismos.
EP3881845A3 (en) Combination of trazodone and gabapentin for the treatment of pain
MX2020008082A (es) Compuestos y composiciones para el tratamiento del dolor.
MX2017013669A (es) Composiciones para el tramiento del cancer.
WO2019022451A3 (ko) 줄기세포로부터 추출된 엑소좀을 유효성분으로 포함하는 골다공증 예방 또는 치료용 조성물